CLRPF
Price
$2.40
Change
+$0.07 (+3.00%)
Updated
Sep 25 closing price
Capitalization
921.02M
ENLV
Price
$1.03
Change
-$0.00 (-0.00%)
Updated
Sep 26 closing price
Capitalization
24.57M
65 days until earnings call
Interact to see
Advertisement

CLRPF vs ENLV

Header iconCLRPF vs ENLV Comparison
Open Charts CLRPF vs ENLVBanner chart's image
Clarity Pharmaceuticals
Price$2.40
Change+$0.07 (+3.00%)
Volume$2K
Capitalization921.02M
Enlivex Therapeutics
Price$1.03
Change-$0.00 (-0.00%)
Volume$124.34K
Capitalization24.57M
CLRPF vs ENLV Comparison Chart in %
Loading...
CLRPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLRPF vs. ENLV commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLRPF is a Buy and ENLV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (CLRPF: $2.38 vs. ENLV: $1.03)
Brand notoriety: CLRPF and ENLV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLRPF: 4% vs. ENLV: 18%
Market capitalization -- CLRPF: $921.02M vs. ENLV: $24.57M
CLRPF [@Biotechnology] is valued at $921.02M. ENLV’s [@Biotechnology] market capitalization is $24.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLRPF’s FA Score shows that 0 FA rating(s) are green whileENLV’s FA Score has 1 green FA rating(s).

  • CLRPF’s FA Score: 0 green, 5 red.
  • ENLV’s FA Score: 1 green, 4 red.
According to our system of comparison, both CLRPF and ENLV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLRPF’s TA Score shows that 3 TA indicator(s) are bullish while ENLV’s TA Score has 2 bullish TA indicator(s).

  • CLRPF’s TA Score: 3 bullish, 7 bearish.
  • ENLV’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, ENLV is a better buy in the short-term than CLRPF.

Price Growth

CLRPF (@Biotechnology) experienced а -5.37% price change this week, while ENLV (@Biotechnology) price change was -1.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

ENLV is expected to report earnings on Dec 01, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLRPF($921M) has a higher market cap than ENLV($24.6M). CLRPF YTD gains are higher at: -11.275 vs. ENLV (-12.393). ENLV has higher annual earnings (EBITDA): -14.21M vs. CLRPF (-78.37M). CLRPF has more cash in the bank: 84.1M vs. ENLV (19.5M).
CLRPFENLVCLRPF / ENLV
Capitalization921M24.6M3,744%
EBITDA-78.37M-14.21M552%
Gain YTD-11.275-12.39391%
P/E RatioN/AN/A-
RevenueN/A0-
Total Cash84.1M19.5M431%
Total DebtN/A480K-
FUNDAMENTALS RATINGS
ENLV: Fundamental Ratings
ENLV
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLRPFENLV
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 25 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
58%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
55%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CLRPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BTCS4.560.04
+0.88%
BTCS
MFC30.770.10
+0.33%
Manulife Financial Corp
RUSHB57.86-0.37
-0.64%
Rush Enterprises
LOMA7.61-0.12
-1.55%
Loma Negra Compania Industrial Argentina Sociedad Anonima
GFAI1.11-0.02
-1.77%
Guardforce AI Co Limited

CLRPF and

Correlation & Price change

A.I.dvisor tells us that CLRPF and ENLV have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLRPF and ENLV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRPF
1D Price
Change %
CLRPF100%
N/A
ENLV - CLRPF
22%
Poorly correlated
-0.49%
JBPHF - CLRPF
14%
Poorly correlated
N/A
MLTX - CLRPF
11%
Poorly correlated
+9.83%
TELIF - CLRPF
10%
Poorly correlated
N/A
ACUT - CLRPF
9%
Poorly correlated
N/A
More

ENLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENLV has been loosely correlated with APVO. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ENLV jumps, then APVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENLV
1D Price
Change %
ENLV100%
-0.49%
APVO - ENLV
36%
Loosely correlated
-6.25%
FENC - ENLV
26%
Poorly correlated
+3.91%
OCUL - ENLV
24%
Poorly correlated
+2.33%
BBIO - ENLV
24%
Poorly correlated
+2.14%
KZIA - ENLV
24%
Poorly correlated
+0.01%
More